Case report: Clinical experience of treating pembrolizumab-induced systemic capillary leak syndrome (SCLS) in one patient with metastatic gastroesophageal junction squamous cell carcinoma

Case report: Clinical experience of treating pembrolizumab-induced systemic capillary leak syndrome (SCLS) in one patient with metastatic gastroesophageal junction squamous cell carcinoma

Systemic capillary leak syndrome (SCLS) is a rare and complex adverse effect of immune checkpoint inhibitors (ICIs). The diagnosis of drug-induced SCLS is based on diffuse infusions of exudative fluid into the interstitial areas and the exclusion of other causes. The best management of ICIs-induced...

Full description

Bibliographic Details
Main Authors: Hua Ni, Xinjia Ding, Shikai Wu, Xuan Jin
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Pathology and Oncology Research
Subjects:
immune checkpoint inhibitor
pembrolizumab
adverse effect
systemic capillary leak syndrome
SCLS
Online Access:https://www.por-journal.com/articles/10.3389/pore.2023.1611330/full

Similar Items

Similar Items